Email ID
Password
Scrip   
Chinese cardiovascular firm turns to US for IPO
27 November 2009
Ian Haydock

China Nuokang Bio-Pharmaceutical has filed for an initial public offering on the Nasdaq Global Market in the US, from which it expects net proceeds of around $41.3 million should this be priced at the mid-range of the offer price.

The choice of bourse suggests that Chinese biopharmaceutical...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36